nodes	percent_of_prediction	percent_of_DWPC	metapath
Apomorphine—HTR2A—coronary artery disease	0.216	1	CbGaD
Apomorphine—HTR1B—Penbutolol—coronary artery disease	0.141	0.615	CbGbCtD
Apomorphine—HTR1A—Penbutolol—coronary artery disease	0.088	0.385	CbGbCtD
Apomorphine—HTR2B—cardial valve—coronary artery disease	0.015	0.274	CbGeAlD
Apomorphine—HTR2A—arteriole—coronary artery disease	0.00496	0.0905	CbGeAlD
Apomorphine—HTR2A—pulmonary artery—coronary artery disease	0.00325	0.0593	CbGeAlD
Apomorphine—HTR2A—sympathetic nervous system—coronary artery disease	0.00316	0.0577	CbGeAlD
Apomorphine—HTR2A—vagus nerve—coronary artery disease	0.00306	0.0559	CbGeAlD
Apomorphine—HTR2A—vein—coronary artery disease	0.00296	0.054	CbGeAlD
Apomorphine—HTR1B—artery—coronary artery disease	0.0025	0.0457	CbGeAlD
Apomorphine—HTR1D—artery—coronary artery disease	0.00242	0.0443	CbGeAlD
Apomorphine—DRD4—heart—coronary artery disease	0.00226	0.0413	CbGeAlD
Apomorphine—HTR2A—autonomic nervous system—coronary artery disease	0.00212	0.0388	CbGeAlD
Apomorphine—HTR2A—artery—coronary artery disease	0.0012	0.022	CbGeAlD
Apomorphine—HTR2A—endothelium—coronary artery disease	0.00102	0.0186	CbGeAlD
Apomorphine—ADRA2C—cardiac ventricle—coronary artery disease	0.000995	0.0182	CbGeAlD
Apomorphine—ADRA2C—myocardium—coronary artery disease	0.000936	0.0171	CbGeAlD
Apomorphine—HTR1B—cardiovascular system—coronary artery disease	0.00087	0.0159	CbGeAlD
Apomorphine—HTR1D—cardiovascular system—coronary artery disease	0.000842	0.0154	CbGeAlD
Apomorphine—HTR2B—heart—coronary artery disease	0.00083	0.0152	CbGeAlD
Apomorphine—HTR2B—cardiovascular system—coronary artery disease	0.000783	0.0143	CbGeAlD
Apomorphine—HTR1A—cardiovascular system—coronary artery disease	0.000702	0.0128	CbGeAlD
Apomorphine—ADRA2C—heart—coronary artery disease	0.000653	0.0119	CbGeAlD
Apomorphine—HTR2B—blood—coronary artery disease	0.00062	0.0113	CbGeAlD
Apomorphine—ADRA2C—cardiac atrium—coronary artery disease	0.000559	0.0102	CbGeAlD
Apomorphine—ADRA2A—heart—coronary artery disease	0.000521	0.00952	CbGeAlD
Apomorphine—ADRA2C—blood—coronary artery disease	0.000488	0.0089	CbGeAlD
Apomorphine—ADRA2A—cardiac atrium—coronary artery disease	0.000446	0.00814	CbGeAlD
Apomorphine—HTR2A—heart—coronary artery disease	0.000443	0.0081	CbGeAlD
Apomorphine—HTR2A—cardiovascular system—coronary artery disease	0.000418	0.00764	CbGeAlD
Apomorphine—ADRA2A—blood—coronary artery disease	0.000389	0.00711	CbGeAlD
Apomorphine—HTR2A—blood—coronary artery disease	0.000331	0.00604	CbGeAlD
Apomorphine—Hypotension—Captopril—coronary artery disease	0.000287	0.0011	CcSEcCtD
Apomorphine—Dyspnoea—Trandolapril—coronary artery disease	0.000287	0.0011	CcSEcCtD
Apomorphine—Somnolence—Trandolapril—coronary artery disease	0.000286	0.0011	CcSEcCtD
Apomorphine—Insomnia—Telmisartan—coronary artery disease	0.000286	0.0011	CcSEcCtD
Apomorphine—Dyspnoea—Enalapril—coronary artery disease	0.000286	0.0011	CcSEcCtD
Apomorphine—Fatigue—Pravastatin—coronary artery disease	0.000286	0.0011	CcSEcCtD
Apomorphine—Vomiting—Acetylsalicylic acid—coronary artery disease	0.000286	0.0011	CcSEcCtD
Apomorphine—Shock—Furosemide—coronary artery disease	0.000286	0.0011	CcSEcCtD
Apomorphine—Somnolence—Enalapril—coronary artery disease	0.000285	0.0011	CcSEcCtD
Apomorphine—Flushing—Lisinopril—coronary artery disease	0.000285	0.00109	CcSEcCtD
Apomorphine—Pruritus—Fenofibrate—coronary artery disease	0.000284	0.00109	CcSEcCtD
Apomorphine—Feeling abnormal—Olmesartan—coronary artery disease	0.000284	0.00109	CcSEcCtD
Apomorphine—Constipation—Pravastatin—coronary artery disease	0.000284	0.00109	CcSEcCtD
Apomorphine—Asthenia—Clopidogrel—coronary artery disease	0.000283	0.00109	CcSEcCtD
Apomorphine—Confusional state—Losartan—coronary artery disease	0.000282	0.00109	CcSEcCtD
Apomorphine—Dyspnoea—Telmisartan—coronary artery disease	0.000282	0.00108	CcSEcCtD
Apomorphine—Asthenia—Lovastatin—coronary artery disease	0.000281	0.00108	CcSEcCtD
Apomorphine—Somnolence—Telmisartan—coronary artery disease	0.000281	0.00108	CcSEcCtD
Apomorphine—Hyperhidrosis—Furosemide—coronary artery disease	0.000281	0.00108	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Captopril—coronary artery disease	0.00028	0.00108	CcSEcCtD
Apomorphine—Oedema—Losartan—coronary artery disease	0.00028	0.00108	CcSEcCtD
Apomorphine—Pruritus—Clopidogrel—coronary artery disease	0.000279	0.00107	CcSEcCtD
Apomorphine—Hypotension—Perindopril—coronary artery disease	0.000279	0.00107	CcSEcCtD
Apomorphine—Insomnia—Captopril—coronary artery disease	0.000278	0.00107	CcSEcCtD
Apomorphine—Fatigue—Trandolapril—coronary artery disease	0.000278	0.00107	CcSEcCtD
Apomorphine—Pruritus—Lovastatin—coronary artery disease	0.000277	0.00107	CcSEcCtD
Apomorphine—Fatigue—Enalapril—coronary artery disease	0.000277	0.00106	CcSEcCtD
Apomorphine—Asthenia—Ezetimibe—coronary artery disease	0.000276	0.00106	CcSEcCtD
Apomorphine—Shock—Losartan—coronary artery disease	0.000276	0.00106	CcSEcCtD
Apomorphine—Constipation—Trandolapril—coronary artery disease	0.000275	0.00106	CcSEcCtD
Apomorphine—Nausea—Rosuvastatin—coronary artery disease	0.000275	0.00106	CcSEcCtD
Apomorphine—Diarrhoea—Fenofibrate—coronary artery disease	0.000275	0.00106	CcSEcCtD
Apomorphine—Constipation—Enalapril—coronary artery disease	0.000274	0.00105	CcSEcCtD
Apomorphine—Dyspnoea—Captopril—coronary artery disease	0.000274	0.00105	CcSEcCtD
Apomorphine—Somnolence—Captopril—coronary artery disease	0.000273	0.00105	CcSEcCtD
Apomorphine—Feeling abnormal—Pravastatin—coronary artery disease	0.000273	0.00105	CcSEcCtD
Apomorphine—Fatigue—Telmisartan—coronary artery disease	0.000273	0.00105	CcSEcCtD
Apomorphine—Pruritus—Ezetimibe—coronary artery disease	0.000272	0.00105	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Perindopril—coronary artery disease	0.000272	0.00105	CcSEcCtD
Apomorphine—Hypotension—Furosemide—coronary artery disease	0.000271	0.00104	CcSEcCtD
Apomorphine—Hyperhidrosis—Losartan—coronary artery disease	0.000271	0.00104	CcSEcCtD
Apomorphine—Constipation—Telmisartan—coronary artery disease	0.000271	0.00104	CcSEcCtD
Apomorphine—Insomnia—Perindopril—coronary artery disease	0.00027	0.00104	CcSEcCtD
Apomorphine—Diarrhoea—Clopidogrel—coronary artery disease	0.00027	0.00104	CcSEcCtD
Apomorphine—Asthenia—Eplerenone—coronary artery disease	0.00027	0.00104	CcSEcCtD
Apomorphine—Mental disorder—Lisinopril—coronary artery disease	0.000269	0.00103	CcSEcCtD
Apomorphine—Diarrhoea—Lovastatin—coronary artery disease	0.000268	0.00103	CcSEcCtD
Apomorphine—Nausea—Acetylsalicylic acid—coronary artery disease	0.000267	0.00103	CcSEcCtD
Apomorphine—Pruritus—Eplerenone—coronary artery disease	0.000266	0.00102	CcSEcCtD
Apomorphine—Dyspnoea—Perindopril—coronary artery disease	0.000266	0.00102	CcSEcCtD
Apomorphine—Dizziness—Fenofibrate—coronary artery disease	0.000266	0.00102	CcSEcCtD
Apomorphine—Somnolence—Perindopril—coronary artery disease	0.000266	0.00102	CcSEcCtD
Apomorphine—Feeling abnormal—Trandolapril—coronary artery disease	0.000265	0.00102	CcSEcCtD
Apomorphine—Fatigue—Captopril—coronary artery disease	0.000265	0.00102	CcSEcCtD
Apomorphine—Feeling abnormal—Enalapril—coronary artery disease	0.000264	0.00102	CcSEcCtD
Apomorphine—Syncope—Ramipril—coronary artery disease	0.000264	0.00101	CcSEcCtD
Apomorphine—Asthenia—Simvastatin—coronary artery disease	0.000263	0.00101	CcSEcCtD
Apomorphine—Diarrhoea—Ezetimibe—coronary artery disease	0.000263	0.00101	CcSEcCtD
Apomorphine—Constipation—Captopril—coronary artery disease	0.000263	0.00101	CcSEcCtD
Apomorphine—Hypotension—Losartan—coronary artery disease	0.000262	0.00101	CcSEcCtD
Apomorphine—Dizziness—Clopidogrel—coronary artery disease	0.000261	0.001	CcSEcCtD
Apomorphine—Feeling abnormal—Telmisartan—coronary artery disease	0.000261	0.001	CcSEcCtD
Apomorphine—Pruritus—Simvastatin—coronary artery disease	0.000259	0.000997	CcSEcCtD
Apomorphine—Dizziness—Lovastatin—coronary artery disease	0.000259	0.000997	CcSEcCtD
Apomorphine—Loss of consciousness—Ramipril—coronary artery disease	0.000259	0.000994	CcSEcCtD
Apomorphine—Back pain—Lisinopril—coronary artery disease	0.000258	0.000992	CcSEcCtD
Apomorphine—Somnolence—Furosemide—coronary artery disease	0.000258	0.000992	CcSEcCtD
Apomorphine—Syncope—Timolol—coronary artery disease	0.000258	0.000992	CcSEcCtD
Apomorphine—Diarrhoea—Eplerenone—coronary artery disease	0.000258	0.00099	CcSEcCtD
Apomorphine—Fatigue—Perindopril—coronary artery disease	0.000257	0.00099	CcSEcCtD
Apomorphine—Constipation—Perindopril—coronary artery disease	0.000255	0.000982	CcSEcCtD
Apomorphine—Vomiting—Fenofibrate—coronary artery disease	0.000255	0.000981	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Losartan—coronary artery disease	0.000255	0.000981	CcSEcCtD
Apomorphine—Dizziness—Ezetimibe—coronary artery disease	0.000254	0.000977	CcSEcCtD
Apomorphine—Feeling abnormal—Captopril—coronary artery disease	0.000253	0.000974	CcSEcCtD
Apomorphine—Insomnia—Losartan—coronary artery disease	0.000253	0.000974	CcSEcCtD
Apomorphine—Loss of consciousness—Timolol—coronary artery disease	0.000253	0.000972	CcSEcCtD
Apomorphine—Headache—Fenofibrate—coronary artery disease	0.000252	0.000967	CcSEcCtD
Apomorphine—Vomiting—Clopidogrel—coronary artery disease	0.000251	0.000965	CcSEcCtD
Apomorphine—Diarrhoea—Simvastatin—coronary artery disease	0.000251	0.000964	CcSEcCtD
Apomorphine—Arthralgia—Ramipril—coronary artery disease	0.000251	0.000963	CcSEcCtD
Apomorphine—Chest pain—Ramipril—coronary artery disease	0.000251	0.000963	CcSEcCtD
Apomorphine—Fatigue—Furosemide—coronary artery disease	0.00025	0.000962	CcSEcCtD
Apomorphine—Dyspnoea—Losartan—coronary artery disease	0.00025	0.00096	CcSEcCtD
Apomorphine—Anxiety—Ramipril—coronary artery disease	0.00025	0.00096	CcSEcCtD
Apomorphine—Vomiting—Lovastatin—coronary artery disease	0.000249	0.000958	CcSEcCtD
Apomorphine—Somnolence—Losartan—coronary artery disease	0.000249	0.000957	CcSEcCtD
Apomorphine—Dizziness—Eplerenone—coronary artery disease	0.000249	0.000957	CcSEcCtD
Apomorphine—Asthenia—Valsartan—coronary artery disease	0.000249	0.000955	CcSEcCtD
Apomorphine—Constipation—Furosemide—coronary artery disease	0.000248	0.000954	CcSEcCtD
Apomorphine—Asthenia—Olmesartan—coronary artery disease	0.000247	0.00095	CcSEcCtD
Apomorphine—Headache—Clopidogrel—coronary artery disease	0.000247	0.00095	CcSEcCtD
Apomorphine—Feeling abnormal—Perindopril—coronary artery disease	0.000246	0.000946	CcSEcCtD
Apomorphine—Headache—Lovastatin—coronary artery disease	0.000246	0.000944	CcSEcCtD
Apomorphine—Pruritus—Valsartan—coronary artery disease	0.000245	0.000942	CcSEcCtD
Apomorphine—Chest pain—Timolol—coronary artery disease	0.000245	0.000941	CcSEcCtD
Apomorphine—Arthralgia—Timolol—coronary artery disease	0.000245	0.000941	CcSEcCtD
Apomorphine—Vomiting—Ezetimibe—coronary artery disease	0.000245	0.00094	CcSEcCtD
Apomorphine—Anxiety—Timolol—coronary artery disease	0.000244	0.000938	CcSEcCtD
Apomorphine—Pruritus—Olmesartan—coronary artery disease	0.000244	0.000937	CcSEcCtD
Apomorphine—Dizziness—Simvastatin—coronary artery disease	0.000243	0.000932	CcSEcCtD
Apomorphine—Confusional state—Ramipril—coronary artery disease	0.000242	0.000931	CcSEcCtD
Apomorphine—Asthenia—Niacin—coronary artery disease	0.000242	0.000929	CcSEcCtD
Apomorphine—Fatigue—Losartan—coronary artery disease	0.000242	0.000928	CcSEcCtD
Apomorphine—Headache—Ezetimibe—coronary artery disease	0.000241	0.000926	CcSEcCtD
Apomorphine—Oedema—Ramipril—coronary artery disease	0.00024	0.000923	CcSEcCtD
Apomorphine—Constipation—Losartan—coronary artery disease	0.00024	0.000921	CcSEcCtD
Apomorphine—Syncope—Lisinopril—coronary artery disease	0.000239	0.00092	CcSEcCtD
Apomorphine—Vomiting—Eplerenone—coronary artery disease	0.000239	0.00092	CcSEcCtD
Apomorphine—Feeling abnormal—Furosemide—coronary artery disease	0.000239	0.000919	CcSEcCtD
Apomorphine—Nausea—Fenofibrate—coronary artery disease	0.000239	0.000917	CcSEcCtD
Apomorphine—Pruritus—Niacin—coronary artery disease	0.000238	0.000916	CcSEcCtD
Apomorphine—Asthenia—Pravastatin—coronary artery disease	0.000238	0.000914	CcSEcCtD
Apomorphine—Diarrhoea—Valsartan—coronary artery disease	0.000237	0.000911	CcSEcCtD
Apomorphine—Confusional state—Timolol—coronary artery disease	0.000237	0.00091	CcSEcCtD
Apomorphine—Shock—Ramipril—coronary artery disease	0.000236	0.000908	CcSEcCtD
Apomorphine—Diarrhoea—Olmesartan—coronary artery disease	0.000236	0.000906	CcSEcCtD
Apomorphine—Headache—Eplerenone—coronary artery disease	0.000236	0.000906	CcSEcCtD
Apomorphine—Oedema—Timolol—coronary artery disease	0.000235	0.000902	CcSEcCtD
Apomorphine—Pruritus—Pravastatin—coronary artery disease	0.000235	0.000902	CcSEcCtD
Apomorphine—Loss of consciousness—Lisinopril—coronary artery disease	0.000235	0.000902	CcSEcCtD
Apomorphine—Nausea—Clopidogrel—coronary artery disease	0.000234	0.000901	CcSEcCtD
Apomorphine—Vomiting—Simvastatin—coronary artery disease	0.000233	0.000896	CcSEcCtD
Apomorphine—Nausea—Lovastatin—coronary artery disease	0.000233	0.000895	CcSEcCtD
Apomorphine—Hyperhidrosis—Ramipril—coronary artery disease	0.000232	0.000892	CcSEcCtD
Apomorphine—Asthenia—Trandolapril—coronary artery disease	0.000231	0.000888	CcSEcCtD
Apomorphine—Shock—Timolol—coronary artery disease	0.000231	0.000888	CcSEcCtD
Apomorphine—Feeling abnormal—Losartan—coronary artery disease	0.000231	0.000887	CcSEcCtD
Apomorphine—Diarrhoea—Niacin—coronary artery disease	0.00023	0.000886	CcSEcCtD
Apomorphine—Asthenia—Enalapril—coronary artery disease	0.00023	0.000884	CcSEcCtD
Apomorphine—Headache—Simvastatin—coronary artery disease	0.00023	0.000883	CcSEcCtD
Apomorphine—Dizziness—Valsartan—coronary artery disease	0.000229	0.00088	CcSEcCtD
Apomorphine—Nausea—Ezetimibe—coronary artery disease	0.000228	0.000878	CcSEcCtD
Apomorphine—Dizziness—Olmesartan—coronary artery disease	0.000228	0.000876	CcSEcCtD
Apomorphine—Pruritus—Trandolapril—coronary artery disease	0.000228	0.000876	CcSEcCtD
Apomorphine—Arthralgia—Lisinopril—coronary artery disease	0.000227	0.000873	CcSEcCtD
Apomorphine—Chest pain—Lisinopril—coronary artery disease	0.000227	0.000873	CcSEcCtD
Apomorphine—Hyperhidrosis—Timolol—coronary artery disease	0.000227	0.000872	CcSEcCtD
Apomorphine—Asthenia—Telmisartan—coronary artery disease	0.000227	0.000872	CcSEcCtD
Apomorphine—Pruritus—Enalapril—coronary artery disease	0.000227	0.000872	CcSEcCtD
Apomorphine—Diarrhoea—Pravastatin—coronary artery disease	0.000227	0.000872	CcSEcCtD
Apomorphine—Anxiety—Lisinopril—coronary artery disease	0.000226	0.00087	CcSEcCtD
Apomorphine—Hypotension—Ramipril—coronary artery disease	0.000224	0.000863	CcSEcCtD
Apomorphine—Pruritus—Telmisartan—coronary artery disease	0.000224	0.00086	CcSEcCtD
Apomorphine—Nausea—Eplerenone—coronary artery disease	0.000224	0.000859	CcSEcCtD
Apomorphine—Dizziness—Niacin—coronary artery disease	0.000223	0.000856	CcSEcCtD
Apomorphine—Asthenia—Captopril—coronary artery disease	0.000221	0.000848	CcSEcCtD
Apomorphine—Diarrhoea—Trandolapril—coronary artery disease	0.00022	0.000847	CcSEcCtD
Apomorphine—Vomiting—Valsartan—coronary artery disease	0.00022	0.000846	CcSEcCtD
Apomorphine—Confusional state—Lisinopril—coronary artery disease	0.00022	0.000844	CcSEcCtD
Apomorphine—Diarrhoea—Enalapril—coronary artery disease	0.000219	0.000843	CcSEcCtD
Apomorphine—Hypotension—Timolol—coronary artery disease	0.000219	0.000843	CcSEcCtD
Apomorphine—Dizziness—Pravastatin—coronary artery disease	0.000219	0.000843	CcSEcCtD
Apomorphine—Vomiting—Olmesartan—coronary artery disease	0.000219	0.000842	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.000219	0.000841	CcSEcCtD
Apomorphine—Nausea—Simvastatin—coronary artery disease	0.000218	0.000837	CcSEcCtD
Apomorphine—Oedema—Lisinopril—coronary artery disease	0.000218	0.000837	CcSEcCtD
Apomorphine—Pruritus—Captopril—coronary artery disease	0.000218	0.000836	CcSEcCtD
Apomorphine—Insomnia—Ramipril—coronary artery disease	0.000217	0.000835	CcSEcCtD
Apomorphine—Headache—Valsartan—coronary artery disease	0.000217	0.000834	CcSEcCtD
Apomorphine—Diarrhoea—Telmisartan—coronary artery disease	0.000216	0.000832	CcSEcCtD
Apomorphine—Headache—Olmesartan—coronary artery disease	0.000216	0.00083	CcSEcCtD
Apomorphine—Shock—Lisinopril—coronary artery disease	0.000214	0.000824	CcSEcCtD
Apomorphine—Asthenia—Perindopril—coronary artery disease	0.000214	0.000824	CcSEcCtD
Apomorphine—Dyspnoea—Ramipril—coronary artery disease	0.000214	0.000823	CcSEcCtD
Apomorphine—Vomiting—Niacin—coronary artery disease	0.000214	0.000823	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Timolol—coronary artery disease	0.000214	0.000822	CcSEcCtD
Apomorphine—Somnolence—Ramipril—coronary artery disease	0.000214	0.000821	CcSEcCtD
Apomorphine—Dizziness—Trandolapril—coronary artery disease	0.000213	0.000818	CcSEcCtD
Apomorphine—Insomnia—Timolol—coronary artery disease	0.000212	0.000816	CcSEcCtD
Apomorphine—Dizziness—Enalapril—coronary artery disease	0.000212	0.000815	CcSEcCtD
Apomorphine—Pruritus—Perindopril—coronary artery disease	0.000211	0.000812	CcSEcCtD
Apomorphine—Headache—Niacin—coronary artery disease	0.000211	0.000811	CcSEcCtD
Apomorphine—Vomiting—Pravastatin—coronary artery disease	0.000211	0.00081	CcSEcCtD
Apomorphine—Hyperhidrosis—Lisinopril—coronary artery disease	0.000211	0.000809	CcSEcCtD
Apomorphine—Diarrhoea—Captopril—coronary artery disease	0.00021	0.000809	CcSEcCtD
Apomorphine—Dyspnoea—Timolol—coronary artery disease	0.000209	0.000805	CcSEcCtD
Apomorphine—Dizziness—Telmisartan—coronary artery disease	0.000209	0.000804	CcSEcCtD
Apomorphine—Somnolence—Timolol—coronary artery disease	0.000209	0.000802	CcSEcCtD
Apomorphine—Asthenia—Furosemide—coronary artery disease	0.000208	0.000801	CcSEcCtD
Apomorphine—Headache—Pravastatin—coronary artery disease	0.000208	0.000798	CcSEcCtD
Apomorphine—Fatigue—Ramipril—coronary artery disease	0.000207	0.000796	CcSEcCtD
Apomorphine—Nausea—Valsartan—coronary artery disease	0.000206	0.000791	CcSEcCtD
Apomorphine—Pruritus—Furosemide—coronary artery disease	0.000205	0.000789	CcSEcCtD
Apomorphine—Constipation—Ramipril—coronary artery disease	0.000205	0.000789	CcSEcCtD
Apomorphine—Nausea—Olmesartan—coronary artery disease	0.000205	0.000787	CcSEcCtD
Apomorphine—Vomiting—Trandolapril—coronary artery disease	0.000205	0.000787	CcSEcCtD
Apomorphine—Diarrhoea—Perindopril—coronary artery disease	0.000204	0.000785	CcSEcCtD
Apomorphine—Vomiting—Enalapril—coronary artery disease	0.000204	0.000784	CcSEcCtD
Apomorphine—Hypotension—Lisinopril—coronary artery disease	0.000204	0.000782	CcSEcCtD
Apomorphine—Dizziness—Captopril—coronary artery disease	0.000203	0.000782	CcSEcCtD
Apomorphine—Fatigue—Timolol—coronary artery disease	0.000202	0.000778	CcSEcCtD
Apomorphine—Headache—Trandolapril—coronary artery disease	0.000202	0.000775	CcSEcCtD
Apomorphine—Vomiting—Telmisartan—coronary artery disease	0.000201	0.000773	CcSEcCtD
Apomorphine—Asthenia—Losartan—coronary artery disease	0.000201	0.000772	CcSEcCtD
Apomorphine—Headache—Enalapril—coronary artery disease	0.000201	0.000772	CcSEcCtD
Apomorphine—Nausea—Niacin—coronary artery disease	0.0002	0.000769	CcSEcCtD
Apomorphine—Diarrhoea—Furosemide—coronary artery disease	0.000199	0.000763	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Lisinopril—coronary artery disease	0.000198	0.000763	CcSEcCtD
Apomorphine—Pruritus—Losartan—coronary artery disease	0.000198	0.000762	CcSEcCtD
Apomorphine—Headache—Telmisartan—coronary artery disease	0.000198	0.000762	CcSEcCtD
Apomorphine—Feeling abnormal—Ramipril—coronary artery disease	0.000198	0.000761	CcSEcCtD
Apomorphine—Dizziness—Perindopril—coronary artery disease	0.000197	0.000759	CcSEcCtD
Apomorphine—Insomnia—Lisinopril—coronary artery disease	0.000197	0.000757	CcSEcCtD
Apomorphine—Nausea—Pravastatin—coronary artery disease	0.000197	0.000757	CcSEcCtD
Apomorphine—Vomiting—Captopril—coronary artery disease	0.000196	0.000752	CcSEcCtD
Apomorphine—Dyspnoea—Lisinopril—coronary artery disease	0.000194	0.000746	CcSEcCtD
Apomorphine—Somnolence—Lisinopril—coronary artery disease	0.000194	0.000744	CcSEcCtD
Apomorphine—Feeling abnormal—Timolol—coronary artery disease	0.000194	0.000744	CcSEcCtD
Apomorphine—Headache—Captopril—coronary artery disease	0.000193	0.000741	CcSEcCtD
Apomorphine—Dizziness—Furosemide—coronary artery disease	0.000192	0.000738	CcSEcCtD
Apomorphine—Diarrhoea—Losartan—coronary artery disease	0.000192	0.000737	CcSEcCtD
Apomorphine—Nausea—Trandolapril—coronary artery disease	0.000191	0.000735	CcSEcCtD
Apomorphine—Nausea—Enalapril—coronary artery disease	0.00019	0.000732	CcSEcCtD
Apomorphine—Vomiting—Perindopril—coronary artery disease	0.00019	0.00073	CcSEcCtD
Apomorphine—Nausea—Telmisartan—coronary artery disease	0.000188	0.000722	CcSEcCtD
Apomorphine—Fatigue—Lisinopril—coronary artery disease	0.000188	0.000722	CcSEcCtD
Apomorphine—Headache—Perindopril—coronary artery disease	0.000187	0.000719	CcSEcCtD
Apomorphine—Constipation—Lisinopril—coronary artery disease	0.000186	0.000716	CcSEcCtD
Apomorphine—Dizziness—Losartan—coronary artery disease	0.000185	0.000712	CcSEcCtD
Apomorphine—Vomiting—Furosemide—coronary artery disease	0.000185	0.000709	CcSEcCtD
Apomorphine—Nausea—Captopril—coronary artery disease	0.000183	0.000702	CcSEcCtD
Apomorphine—Headache—Furosemide—coronary artery disease	0.000182	0.000699	CcSEcCtD
Apomorphine—Feeling abnormal—Lisinopril—coronary artery disease	0.00018	0.00069	CcSEcCtD
Apomorphine—Vomiting—Losartan—coronary artery disease	0.000178	0.000685	CcSEcCtD
Apomorphine—Nausea—Perindopril—coronary artery disease	0.000177	0.000682	CcSEcCtD
Apomorphine—Headache—Losartan—coronary artery disease	0.000175	0.000674	CcSEcCtD
Apomorphine—Nausea—Furosemide—coronary artery disease	0.000172	0.000663	CcSEcCtD
Apomorphine—Asthenia—Ramipril—coronary artery disease	0.000172	0.000662	CcSEcCtD
Apomorphine—Pruritus—Ramipril—coronary artery disease	0.00017	0.000653	CcSEcCtD
Apomorphine—Asthenia—Timolol—coronary artery disease	0.000168	0.000647	CcSEcCtD
Apomorphine—Nausea—Losartan—coronary artery disease	0.000166	0.000639	CcSEcCtD
Apomorphine—Pruritus—Timolol—coronary artery disease	0.000166	0.000638	CcSEcCtD
Apomorphine—Diarrhoea—Ramipril—coronary artery disease	0.000164	0.000632	CcSEcCtD
Apomorphine—Diarrhoea—Timolol—coronary artery disease	0.000161	0.000617	CcSEcCtD
Apomorphine—Dizziness—Ramipril—coronary artery disease	0.000159	0.00061	CcSEcCtD
Apomorphine—Asthenia—Lisinopril—coronary artery disease	0.000156	0.000601	CcSEcCtD
Apomorphine—Dizziness—Timolol—coronary artery disease	0.000155	0.000597	CcSEcCtD
Apomorphine—Pruritus—Lisinopril—coronary artery disease	0.000154	0.000592	CcSEcCtD
Apomorphine—Vomiting—Ramipril—coronary artery disease	0.000153	0.000587	CcSEcCtD
Apomorphine—Headache—Ramipril—coronary artery disease	0.00015	0.000578	CcSEcCtD
Apomorphine—Vomiting—Timolol—coronary artery disease	0.000149	0.000574	CcSEcCtD
Apomorphine—Diarrhoea—Lisinopril—coronary artery disease	0.000149	0.000573	CcSEcCtD
Apomorphine—Headache—Timolol—coronary artery disease	0.000147	0.000565	CcSEcCtD
Apomorphine—Dizziness—Lisinopril—coronary artery disease	0.000144	0.000554	CcSEcCtD
Apomorphine—Nausea—Ramipril—coronary artery disease	0.000143	0.000548	CcSEcCtD
Apomorphine—Nausea—Timolol—coronary artery disease	0.000139	0.000536	CcSEcCtD
Apomorphine—Vomiting—Lisinopril—coronary artery disease	0.000139	0.000532	CcSEcCtD
Apomorphine—Headache—Lisinopril—coronary artery disease	0.000136	0.000524	CcSEcCtD
Apomorphine—Nausea—Lisinopril—coronary artery disease	0.000129	0.000497	CcSEcCtD
Apomorphine—ADRA2A—Signaling Pathways—KDR—coronary artery disease	3.34e-06	1.39e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling by GPCR—AKT1—coronary artery disease	3.32e-06	1.38e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MAPK14—coronary artery disease	3.32e-06	1.38e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—CCND1—coronary artery disease	3.31e-06	1.38e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—CXCL8—coronary artery disease	3.31e-06	1.38e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—CXCL8—coronary artery disease	3.31e-06	1.38e-05	CbGpPWpGaD
Apomorphine—ADRA2C—GPCR downstream signaling—PIK3CA—coronary artery disease	3.3e-06	1.37e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—GSK3B—coronary artery disease	3.3e-06	1.37e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—FGF2—coronary artery disease	3.29e-06	1.37e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—SERPINE1—coronary artery disease	3.29e-06	1.37e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—FGF2—coronary artery disease	3.28e-06	1.37e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—JAK2—coronary artery disease	3.27e-06	1.36e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—POMC—coronary artery disease	3.27e-06	1.36e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CREB1—coronary artery disease	3.27e-06	1.36e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling by GPCR—AKT1—coronary artery disease	3.27e-06	1.36e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—ESR1—coronary artery disease	3.25e-06	1.36e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—NOS3—coronary artery disease	3.25e-06	1.35e-05	CbGpPWpGaD
Apomorphine—ADRA1B—GPCR downstream signaling—PIK3CA—coronary artery disease	3.25e-06	1.35e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—GSK3B—coronary artery disease	3.24e-06	1.35e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—SERPINE1—coronary artery disease	3.24e-06	1.35e-05	CbGpPWpGaD
Apomorphine—DRD1—GPCR downstream signaling—AKT1—coronary artery disease	3.24e-06	1.35e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—NOS3—coronary artery disease	3.23e-06	1.35e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—POMC—coronary artery disease	3.22e-06	1.34e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CREB1—coronary artery disease	3.22e-06	1.34e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—MMP9—coronary artery disease	3.21e-06	1.34e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—FN1—coronary artery disease	3.21e-06	1.34e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—F2—coronary artery disease	3.21e-06	1.34e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—CASP3—coronary artery disease	3.21e-06	1.34e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—PIK3CA—coronary artery disease	3.21e-06	1.34e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IL6ST—coronary artery disease	3.2e-06	1.33e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CCL2—coronary artery disease	3.2e-06	1.33e-05	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—PIK3CA—coronary artery disease	3.2e-06	1.33e-05	CbGpPWpGaD
Apomorphine—DRD3—GPCR downstream signaling—AKT1—coronary artery disease	3.19e-06	1.33e-05	CbGpPWpGaD
Apomorphine—ADRA1D—GPCR downstream signaling—AKT1—coronary artery disease	3.19e-06	1.33e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—ALB—coronary artery disease	3.19e-06	1.33e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—IL6R—coronary artery disease	3.19e-06	1.33e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—FGF2—coronary artery disease	3.19e-06	1.33e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling by GPCR—IL6—coronary artery disease	3.19e-06	1.33e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—NFKBIA—coronary artery disease	3.18e-06	1.32e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—CASP3—coronary artery disease	3.17e-06	1.32e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—CASP3—coronary artery disease	3.17e-06	1.32e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—JAK2—coronary artery disease	3.16e-06	1.32e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CCL2—coronary artery disease	3.15e-06	1.31e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—IGF1—coronary artery disease	3.15e-06	1.31e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling by GPCR—IL6—coronary artery disease	3.14e-06	1.31e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling by GPCR—IL6—coronary artery disease	3.14e-06	1.31e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—NOS3—coronary artery disease	3.14e-06	1.31e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—JAK2—coronary artery disease	3.14e-06	1.31e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—IL6R—coronary artery disease	3.14e-06	1.31e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—VEGFA—coronary artery disease	3.14e-06	1.31e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—FGF2—coronary artery disease	3.14e-06	1.31e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—MAPK1—coronary artery disease	3.13e-06	1.31e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—CCND1—coronary artery disease	3.12e-06	1.3e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling by GPCR—AKT1—coronary artery disease	3.12e-06	1.3e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—IGF1—coronary artery disease	3.1e-06	1.29e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—PIK3CA—coronary artery disease	3.09e-06	1.29e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—NOS3—coronary artery disease	3.09e-06	1.29e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—MAPK1—coronary artery disease	3.08e-06	1.28e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—CCND1—coronary artery disease	3.08e-06	1.28e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—CCND1—coronary artery disease	3.08e-06	1.28e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—PIK3CA—coronary artery disease	3.08e-06	1.28e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—KIT—coronary artery disease	3.08e-06	1.28e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—VEGFA—coronary artery disease	3.07e-06	1.28e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—JAK2—coronary artery disease	3.06e-06	1.27e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—NOS3—coronary artery disease	3.05e-06	1.27e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—MMP9—coronary artery disease	3.03e-06	1.26e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—VEGFA—coronary artery disease	3.02e-06	1.26e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—JAK2—coronary artery disease	3.01e-06	1.25e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—PIK3CA—coronary artery disease	2.99e-06	1.25e-05	CbGpPWpGaD
Apomorphine—DRD2—GPCR downstream signaling—PIK3CA—coronary artery disease	2.99e-06	1.25e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—MMP9—coronary artery disease	2.99e-06	1.25e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—MMP9—coronary artery disease	2.99e-06	1.25e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—SERPINE1—coronary artery disease	2.99e-06	1.25e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—CXCL8—coronary artery disease	2.99e-06	1.24e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—GSK3B—coronary artery disease	2.95e-06	1.23e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—PIK3CA—coronary artery disease	2.95e-06	1.23e-05	CbGpPWpGaD
Apomorphine—HTR2A—GPCR downstream signaling—PIK3CA—coronary artery disease	2.94e-06	1.23e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling by GPCR—AKT1—coronary artery disease	2.94e-06	1.23e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—SERPINE1—coronary artery disease	2.94e-06	1.23e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—POMC—coronary artery disease	2.93e-06	1.22e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CREB1—coronary artery disease	2.93e-06	1.22e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling by GPCR—AKT1—coronary artery disease	2.9e-06	1.21e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling by GPCR—AKT1—coronary artery disease	2.9e-06	1.21e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—FGF2—coronary artery disease	2.89e-06	1.21e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—VEGFA—coronary artery disease	2.89e-06	1.2e-05	CbGpPWpGaD
Apomorphine—ADRA2B—GPCR downstream signaling—AKT1—coronary artery disease	2.88e-06	1.2e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CXCL8—coronary artery disease	2.88e-06	1.2e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—TGFB1—coronary artery disease	2.88e-06	1.2e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CXCL8—coronary artery disease	2.87e-06	1.19e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CCL2—coronary artery disease	2.87e-06	1.19e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—CASP3—coronary artery disease	2.86e-06	1.19e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IL6R—coronary artery disease	2.86e-06	1.19e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—NOS3—coronary artery disease	2.85e-06	1.19e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—FGF2—coronary artery disease	2.85e-06	1.19e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—IL6—coronary artery disease	2.84e-06	1.18e-05	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—IL6—coronary artery disease	2.83e-06	1.18e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—MAPK1—coronary artery disease	2.82e-06	1.18e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—TGFB1—coronary artery disease	2.82e-06	1.18e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IGF1—coronary artery disease	2.82e-06	1.17e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—NOS3—coronary artery disease	2.81e-06	1.17e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—MAPK1—coronary artery disease	2.8e-06	1.17e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—PTGS2—coronary artery disease	2.79e-06	1.16e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CXCL8—coronary artery disease	2.79e-06	1.16e-05	CbGpPWpGaD
Apomorphine—HTR1A—GPCR downstream signaling—AKT1—coronary artery disease	2.78e-06	1.16e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—CCND1—coronary artery disease	2.78e-06	1.16e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—TGFB1—coronary artery disease	2.78e-06	1.16e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—JAK2—coronary artery disease	2.77e-06	1.16e-05	CbGpPWpGaD
Apomorphine—HTR2C—GPCR downstream signaling—AKT1—coronary artery disease	2.77e-06	1.15e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—MAPK1—coronary artery disease	2.77e-06	1.15e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CASP3—coronary artery disease	2.76e-06	1.15e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CXCL8—coronary artery disease	2.74e-06	1.14e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CASP3—coronary artery disease	2.74e-06	1.14e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—IL6—coronary artery disease	2.74e-06	1.14e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—JAK2—coronary artery disease	2.73e-06	1.14e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—IL6—coronary artery disease	2.73e-06	1.14e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—VEGFA—coronary artery disease	2.72e-06	1.13e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—MAPK1—coronary artery disease	2.72e-06	1.13e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—PIK3CA—coronary artery disease	2.72e-06	1.13e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—MMP9—coronary artery disease	2.7e-06	1.13e-05	CbGpPWpGaD
Apomorphine—ADRA2C—GPCR downstream signaling—AKT1—coronary artery disease	2.69e-06	1.12e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—VEGFA—coronary artery disease	2.69e-06	1.12e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—VEGFA—coronary artery disease	2.69e-06	1.12e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CCND1—coronary artery disease	2.68e-06	1.12e-05	CbGpPWpGaD
Apomorphine—ADRA2A—GPCR downstream signaling—PIK3CA—coronary artery disease	2.68e-06	1.12e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—SERPINE1—coronary artery disease	2.67e-06	1.11e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—PIK3CA—coronary artery disease	2.67e-06	1.11e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CCND1—coronary artery disease	2.67e-06	1.11e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CASP3—coronary artery disease	2.67e-06	1.11e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—IL6—coronary artery disease	2.65e-06	1.11e-05	CbGpPWpGaD
Apomorphine—ADRA1B—GPCR downstream signaling—AKT1—coronary artery disease	2.65e-06	1.11e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—TGFB1—coronary artery disease	2.65e-06	1.1e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CASP3—coronary artery disease	2.63e-06	1.09e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—AKT1—coronary artery disease	2.62e-06	1.09e-05	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—AKT1—coronary artery disease	2.61e-06	1.09e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—IL6—coronary artery disease	2.61e-06	1.09e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—MMP9—coronary artery disease	2.61e-06	1.09e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CCND1—coronary artery disease	2.6e-06	1.08e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—MAPK1—coronary artery disease	2.6e-06	1.08e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—MMP9—coronary artery disease	2.59e-06	1.08e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	2.59e-06	1.08e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CCND1—coronary artery disease	2.56e-06	1.07e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	2.55e-06	1.06e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CXCL8—coronary artery disease	2.53e-06	1.05e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	2.53e-06	1.05e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—MMP9—coronary artery disease	2.52e-06	1.05e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—AKT1—coronary artery disease	2.52e-06	1.05e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—TGFB1—coronary artery disease	2.5e-06	1.04e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	2.49e-06	1.04e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—MMP9—coronary artery disease	2.48e-06	1.03e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	2.48e-06	1.03e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—TGFB1—coronary artery disease	2.47e-06	1.03e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—TGFB1—coronary artery disease	2.47e-06	1.03e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—PIK3CA—coronary artery disease	2.45e-06	1.02e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—MAPK1—coronary artery disease	2.45e-06	1.02e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—AKT1—coronary artery disease	2.45e-06	1.02e-05	CbGpPWpGaD
Apomorphine—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	2.44e-06	1.02e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	2.43e-06	1.01e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—VEGFA—coronary artery disease	2.42e-06	1.01e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CASP3—coronary artery disease	2.42e-06	1.01e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—MAPK1—coronary artery disease	2.42e-06	1.01e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—MAPK1—coronary artery disease	2.42e-06	1.01e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—AKT1—coronary artery disease	2.41e-06	1e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—IL6—coronary artery disease	2.41e-06	1e-05	CbGpPWpGaD
Apomorphine—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	2.41e-06	1e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—PIK3CA—coronary artery disease	2.4e-06	1e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CASP3—coronary artery disease	2.38e-06	9.93e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—IL6—coronary artery disease	2.37e-06	9.87e-06	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—PIK3CA—coronary artery disease	2.36e-06	9.84e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CCND1—coronary artery disease	2.36e-06	9.83e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	2.34e-06	9.76e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—VEGFA—coronary artery disease	2.33e-06	9.71e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CCND1—coronary artery disease	2.32e-06	9.67e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MMP9—coronary artery disease	2.29e-06	9.54e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	2.27e-06	9.44e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—VEGFA—coronary artery disease	2.26e-06	9.44e-06	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—PIK3CA—coronary artery disease	2.25e-06	9.4e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MMP9—coronary artery disease	2.25e-06	9.39e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—VEGFA—coronary artery disease	2.23e-06	9.29e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—TGFB1—coronary artery disease	2.23e-06	9.28e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—AKT1—coronary artery disease	2.22e-06	9.25e-06	CbGpPWpGaD
Apomorphine—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	2.19e-06	9.12e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	2.18e-06	9.1e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—MAPK1—coronary artery disease	2.18e-06	9.1e-06	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—IL6—coronary artery disease	2.17e-06	9.05e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	2.17e-06	9.04e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	2.15e-06	8.98e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	2.15e-06	8.95e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—TGFB1—coronary artery disease	2.14e-06	8.91e-06	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—PIK3CA—coronary artery disease	2.13e-06	8.86e-06	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—IL6—coronary artery disease	2.13e-06	8.86e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—PIK3CA—coronary artery disease	2.12e-06	8.82e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	2.11e-06	8.8e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	2.11e-06	8.78e-06	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—PIK3CA—coronary artery disease	2.1e-06	8.74e-06	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—PIK3CA—coronary artery disease	2.1e-06	8.74e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—MAPK1—coronary artery disease	2.1e-06	8.74e-06	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—IL6—coronary artery disease	2.09e-06	8.72e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—TGFB1—coronary artery disease	2.08e-06	8.66e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—VEGFA—coronary artery disease	2.06e-06	8.57e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	2.05e-06	8.54e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—TGFB1—coronary artery disease	2.05e-06	8.53e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—MAPK1—coronary artery disease	2.04e-06	8.5e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	2.02e-06	8.43e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—MAPK1—coronary artery disease	2.01e-06	8.36e-06	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—AKT1—coronary artery disease	2e-06	8.35e-06	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—IL6—coronary artery disease	2e-06	8.32e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	1.99e-06	8.28e-06	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—AKT1—coronary artery disease	1.96e-06	8.17e-06	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—AKT1—coronary artery disease	1.93e-06	8.04e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—PIK3CA—coronary artery disease	1.89e-06	7.89e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—TGFB1—coronary artery disease	1.89e-06	7.86e-06	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—IL6—coronary artery disease	1.88e-06	7.85e-06	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—IL6—coronary artery disease	1.86e-06	7.74e-06	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—IL6—coronary artery disease	1.86e-06	7.74e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	1.86e-06	7.74e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MAPK1—coronary artery disease	1.85e-06	7.71e-06	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—AKT1—coronary artery disease	1.84e-06	7.68e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	1.84e-06	7.67e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	1.83e-06	7.62e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	1.82e-06	7.59e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—PIK3CA—coronary artery disease	1.82e-06	7.58e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—PIK3CA—coronary artery disease	1.77e-06	7.37e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—PIK3CA—coronary artery disease	1.74e-06	7.26e-06	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—AKT1—coronary artery disease	1.74e-06	7.24e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—AKT1—coronary artery disease	1.73e-06	7.2e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—PIK3CA—coronary artery disease	1.72e-06	7.16e-06	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—AKT1—coronary artery disease	1.71e-06	7.14e-06	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—AKT1—coronary artery disease	1.71e-06	7.14e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	1.69e-06	7.04e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—IL6—coronary artery disease	1.68e-06	6.99e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	1.66e-06	6.9e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—IL6—coronary artery disease	1.62e-06	6.75e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—IL6—coronary artery disease	1.61e-06	6.71e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	1.61e-06	6.69e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	1.58e-06	6.58e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—IL6—coronary artery disease	1.57e-06	6.53e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—AKT1—coronary artery disease	1.55e-06	6.45e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—IL6—coronary artery disease	1.54e-06	6.43e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—AKT1—coronary artery disease	1.49e-06	6.22e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—AKT1—coronary artery disease	1.49e-06	6.19e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—AKT1—coronary artery disease	1.45e-06	6.02e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	1.44e-06	5.99e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—AKT1—coronary artery disease	1.42e-06	5.93e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—IL6—coronary artery disease	1.42e-06	5.92e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—AKT1—coronary artery disease	1.4e-06	5.85e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—IL6—coronary artery disease	1.4e-06	5.83e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—AKT1—coronary artery disease	1.31e-06	5.47e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—AKT1—coronary artery disease	1.29e-06	5.38e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IL6—coronary artery disease	1.27e-06	5.3e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	1.17e-06	4.89e-06	CbGpPWpGaD
